Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial

Overview of attention for article published in BMC Pulmonary Medicine, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 103 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,157 followers.

https://t.co/k16VLp6CSF

26 Aug 2020

Reply Repost Favourite

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe #COPD: a randomized cross-over trial https://t.co/zLkXs2lb7r https://t.co/7ZBLjF7S8H

14 Jun 2018

Reply Repost Favourite